| 英文名称 |
中文名称 |
CAS号 |
操作 |
| Parogrelil - NT 702, free base | NM 702 |
4-溴-6-[3-(4-氯苯基)丙氧基]-5-[(3-吡啶甲基)氨基]-3(2H)-哒嗪酮 |
139145-27-0 |
详细
|
| NU 1025 |
NU1025 |
90417-38-2 |
详细
|
| NVP-TAE684 - TAE 684 |
NVP-TAE684 |
761439-42-3 |
详细
|
| Palbociclib isethionate - PD 0332991 isethionate |
帕布昔利布羟乙基磺酸盐 |
827022-33-3 |
详细
|
| P 22077 |
P 22077 |
1247819-59-5 |
详细
|
| MJN110 |
MJN110 |
1438416-21-7 |
详细
|
| N 0425 hydrochloride - N-methyl-N-propargyl-2-aminotetralin hydrochloride |
|
78621-26-8 |
详细
|
| PBTZ169 |
PBTZ169 |
1377239-83-2 |
详细
|
| NCL-00017509 |
NCL-00017509 |
1507367-00-1 |
详细
|
| Paroxetine hydrochloride |
盐酸帕罗西汀 |
110429-35-1 |
详细
|
| PCI 32765 - Ibrutinib |
依鲁替尼 |
936563-96-1 |
详细
|
| P 005091 - P 5091 |
P005091 |
882257-11-6 |
详细
|
| ML 323 |
ML323 |
1572414-83-5 |
详细
|
| ML 210 - CID 49766530 |
[4-[Bis(4-chlorophenyl)methyl]piperazin-1-yl]-(5-methyl-4-nitro-1,2-oxazol-3-yl)methanone |
1360705-96-9 |
详细
|
| Nolatrexed dihydrochloride - AG 337 | Thymitaq |
盐酸诺拉曲塞 |
152946-68-4 |
详细
|
| PD 184352 - CI 1040 |
2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺 |
212631-79-3 |
详细
|
| NVP-AUY922 - VER 52296 | Luminespib |
NVP-AUY922 |
747412-49-3 |
详细
|
| OSU 03012 |
2-氨基-N-[4-[5-(2-菲基)-3-(三氟甲基)-1H-吡唑-1-基]苯基]乙酰胺 |
742112-33-0 |
详细
|
| ONX 0914 - PR 957 |
ONX-0914 |
960374-59-8 |
详细
|
| OG-L002 hydrochloride |
OGL002; OG L002 |
1357298-75-9 |
详细
|
| ML364 |
2-(4-甲基苯磺胺基)-N-(4-苯基噻唑-2-基)-4-三氟甲基苯甲酰胺 |
1991986-30-1 |
详细
|
| MYK-461 - Mavacamten | SAR439152 |
玛伐凯泰 |
1642288-47-8 |
详细
|
| MS 275 - Entinostat | SNDX 275 |
恩替诺特 |
209783-80-2 |
详细
|
| Miglitol |
米格列醇 |
72432-03-2 |
详细
|
| Nutlin-3a - Nutlin-3, (-)- |
Nutlin 3a |
675576-98-4 |
详细
|
| Odiparcil - SB 424323 | GSK 424323 |
137215-12-4 |
137215-12-4 |
详细
|
| PD 98059 - NSC 679828 |
2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮 |
167869-21-8 |
详细
|
| NSC 23766 |
NSC23766 |
1177865-17-6 |
详细
|
| MG 132 |
MG132,蛋白酶体抑制剂 |
133407-82-6 |
详细
|
| NSC 625987 |
NSC 625987 |
141992-47-4 |
详细
|
| PD 166793 |
N-[(4'-溴[1,1'-联苯]-4-基)磺酰基]-L-缬氨酸 |
199850-67-4 |
详细
|
| PD 0325901 |
N-[(2R)-2,3-二羟基丙氧基]-3,4-二氟-2-[(2-氟-4-碘苯)氨基]苯甲酰胺 |
391210-10-9 |
详细
|
| Mocetinostat - MGCD 0103 | MG 0103 |
N-(2-氨基苯基)-4-([[4-(吡啶-3-基)嘧啶-2-基]氨基]甲基)苯甲酰胺 |
726169-73-9 |
详细
|
| NVP 231 |
NVP-231 |
362003-83-6 |
详细
|
| NQDI 1 |
NQDI 1 |
175026-96-7 |
详细
|
| P 505-15 - PRT 062607 |
2-[[(1R,2S)-2-氨基环己基]氨基]-4-[[3-(2H-1,2,3-三唑-2-基)苯基]氨基]-5-嘧啶甲酰胺 |
1370261-96-3 |
详细
|
| Nutlin-3b - Nutlin-3, (+)- |
Nutlin-3b |
675576-97-3 |
详细
|
| Mps1-IN-2 |
9-环戊基-2-[[2-乙氧基-4-(4-羟基哌啶-1-基)苯基]氨基]-5-甲基-8,9-二氢-5H-嘧啶并[4,5-B][1,4]二氮杂卓-6(7H)-酮 |
1228817-38-6 |
详细
|
| NVP-TNKS656 - TNKS 656 |
NVP-TNKS656 |
1419949-20-4 |
详细
|
| ML346 - CID 767276 |
ML346 |
100872-83-1 |
详细
|
| MHY 908 |
MHY 908 |
1393371-39-5 |
详细
|
| Naive Stem Cell 5i inhibitor Set |
|
|
详细
|
| NS 3694 |
NS 3694 |
426834-38-0 |
详细
|
| Nutlin-3 |
REL-4-[[(4R,5S)-4,5-双(4-氯苯基)-4,5-二氢-2-[4-甲氧基-2-(1-甲基乙氧基)苯基]-1H-咪唑-1-基]羰基]-2-哌嗪酮 |
548472-68-0 |
详细
|
| Nelfinavir mesylate - AG 1343 |
甲磺酸奈非那韦 |
159989-65-8 |
详细
|
| N 0430 hydrobromide |
|
96333-04-9 |
详细
|
| MK 0822 - Odanacatib |
(2S)-N-(1-氰基环丙基)-4-氟-4-甲基-2-[[(1S)-2,2,2-三氟-1-[4'-(甲基磺酰基)[1,1'-联苯]-4-基]乙基]氨基]戊酰胺 |
603139-19-1 |
详细
|
| Palomid 529 - SG 00529 |
PALOMID 529 (P529) |
914913-88-5 |
详细
|
| NVP-BGT226 - BGT 226 |
NVP-BGT226 |
1245537-68-1 |
详细
|
| PCI 34051 |
N-羟基-1-(4-甲氧基苄基)-1H-吲哚-6-甲酰胺 |
950762-95-5 |
详细
|
| Nexturastat A |
4-((1-BUTYL-3-PHENYLUREIDO)METHYL)-N-HYDROXYBENZAMIDE |
1403783-31-2 |
详细
|
| ML 324 dihydrochloride |
ML 324 dihydrochloride |
2108968-53-0 |
详细
|
| ONO 5334 |
ONO 5334 |
868273-90-9 |
详细
|
| ML348 |
CS-2370 |
899713-86-1 |
详细
|
| Nilotinib - AMN 107 | Tasigna |
尼罗替尼 |
641571-10-0 |
详细
|
| MLR 1023 - Tolimidone | CP 26154 |
托利咪酮 |
41964-07-2 |
详细
|
| MLN 8237 - Alisertib |
阿立塞替 |
1028486-01-2 |
详细
|
| MLN 2238 - Ixazomib |
艾沙佐米 |
1072833-77-2 |
详细
|
| P7C3 |
P7C3 |
301353-96-8 |
详细
|
| NVP-BSK805 - BSK 805 |
NVP-BSK805 dihydrochloride |
1092499-93-8 |
详细
|
| MK 5108 - VX 689 |
MK-5108 (VX-689) |
1010085-13-8 |
详细
|
| ML 355 |
ML355 |
1532593-30-8 |
详细
|
| OSS-128167 |
OSS-128167 |
887686-02-4 |
详细
|
| MSTP |
MSTP |
2125668-23-5 |
详细
|
| Olprinone hydrochloride - Loprinone hydrochloride |
盐酸奥普力农 |
119615-63-3 |
详细
|
| Necrostatin-1 |
NECROSTATIN-1 |
4311-88-0 |
详细
|
| PAC 1 - Procaspase activating compound 1 |
PAC1 |
315183-21-2 |
详细
|
| N 0425 hydrochloride, (-)- - N-methyl-N-propargyl-2-aminotetralin hydrochloride, (-)- |
|
98640-73-4 |
详细
|
| MK 2206 |
MK-2206 2HCl |
1032350-13-2 |
详细
|
| Nintedanib - BIBF-1120 |
尼达尼布 |
656247-17-5 |
详细
|
| MG 149 |
MG149 |
1243583-85-8 |
详细
|
| MLN 0905 |
2-[[5-[3-(二甲基氨基)丙基]-2-甲基-3-吡啶基]氨基]-5,7-二氢-9-(三氟甲基)- 6H-嘧啶并[5,4-D][1]苯并氮杂卓-6-硫酮 |
1228960-69-7 |
详细
|
| PD 0332991 hydrochloride - Palbociclib hydrochloride |
6-乙酰基-8-环戊基-5-甲基-2-[[5-(1-哌嗪基)-2-吡啶基]氨基]吡啶并[2,3-D]嘧啶-7(8H)-酮盐酸盐 |
571189-11-2 |
详细
|
| Mitapivat |
PKR-IN-1 |
1260075-17-9 |
详细
|
| N106 |
N-(4-甲氧基苯并[D]噻唑-2-基)-5-(4-甲氧基苯基)-1,3,4-噁二唑-2-胺 |
862974-25-2 |
详细
|
| NHI 2 |
NHI 2 |
1269802-97-2 |
详细
|
| PDE9A inhibitor C33(S) - (S)-C33 |
(S)-C33 |
2066488-39-7 |
详细
|
| Naive Stem Cell NHSM inhibitor Set - Stem Cell 6i inhibitor Set |
|
|
详细
|
| PD 169316 |
4-[4-(4-氟苯基)-2-(4-硝基苯基)-1H-咪唑-5-基]吡啶 |
152121-53-4 |
详细
|
| NQ301 - Compound 211 |
NQ301 |
130089-98-4 |
详细
|
| PD 180970 |
PD180970 |
287204-45-9 |
详细
|
| NVP-BKM120 - BKM 120 |
BKM-120 |
944396-07-0 |
详细
|
| Niraparib - MK 4827 |
尼拉帕尼 |
1038915-60-4 |
详细
|
| MK 1775 - AZD 1775 | Adavosertib |
MK-1775 |
955365-80-7 |
详细
|
| MLN 9708 - Ixazomib citrate |
艾沙佐米柠檬酸盐 |
1201902-80-8 |
详细
|
| NSC 405020 |
NSC 405020 |
7497-07-6 |
详细
|
| ME0328 |
ME0328 |
1445251-22-8 |
详细
|
| ML 351 |
ML 351 |
847163-28-4 |
详细
|
| PDE5 inhibitor 42 |
PDE5 inhibitor 42 |
936449-28-4 |
详细
|
| NCT-503 |
NCT503 |
1916571-90-8 |
详细
|
| NM-PP1, 1- |
4-氨基1-叔丁基-3-(1'-萘甲基)吡唑并[3,4-D]嘧啶 |
221244-14-0 |
详细
|
| N 0425 hydrochloride, (+)- - N-methyl-N-propargyl-2-aminotetralin hydrochloride, (+)- |
|
98640-74-5 |
详细
|
| NU 7441 - KU 47788 |
8-(4-二苯并噻吩基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 |
503468-95-9 |
详细
|
| MLN 4924 - Pevonedistat |
氨基磺酸 [(1S,2S,4R)-4-[4-[[(1S)-2,3-二氢-1H-茚-1-基]氨基]-7H-吡咯并[2,3-D]嘧啶-7-基]-2-羟基环戊基]甲基酯 |
905579-51-3 |
详细
|
| N 6022 |
N6022 |
1208315-24-5 |
详细
|
| NVP-BBD130 - BBD 130 |
2-甲基-2-[4-[3-甲基-2-氧代-8-[(吡啶-3-基)乙炔基]-2,3-二氢咪唑并[4,5-C]喹啉-1-基]苯基]丙腈 |
853910-61-9 |
详细
|
| NSC 687852 - b-AP15 |
b-AP15 |
1009817-63-3 |
详细
|
| MHY 1485 |
MHY1485 |
326914-06-1 |
详细
|
| NG 25 trihydrochloride |
|
2108554-00-1 |
详细
|
| NSC 756093 |
NSC 756093 |
1629908-92-4 |
详细
|